MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
Milestone Scientific EV/EBITDA Ratio 2011-2025 | MLSS
Annual EV/EBITDA Ratio Milestone Scientific
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -7.89 | -22.1 | -21.1 | -2.4 | -6.38 | -4.74 | -11 | -63.7 | 20.8 | -47.9 | -7.1 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 20.8 | -63.7 | -15.8 |
EV/EBITDA Ratio of other stocks in the Medical instruments industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Baxter International
BAX
|
24.7 | $ 18.99 | 0.48 % | $ 9.68 B |  USA |
 |
Becton, Dickinson and Company
BDX
|
13.6 | $ 200.87 | 0.22 % | $ 57.8 B | USA |
 |
BioLife Solutions
BLFS
|
-38.3 | $ 24.43 | -1.81 % | $ 1.13 B | USA |
 |
Luminex Corporation
LMNX
|
15.9 | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
-0.0238 | - | -9.52 % | $ 20.6 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
0.307 | $ 4.79 | 2.35 % | $ 96.6 M | USA |
 |
DENTSPLY SIRONA
XRAY
|
11.9 | $ 11.59 | -0.13 % | $ 2.36 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
44 | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
24.9 | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
6.47 | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
14.8 | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
252 | - | -0.02 % | $ 16.3 B | USA |
 |
Alcon
ALC
|
72.7 | $ 78.74 | -0.03 % | $ 40.4 B |  Schweiz |
 |
iRhythm Technologies
IRTC
|
-38.7 | $ 170.09 | 0.58 % | $ 5.31 B | USA |
 |
AtriCure
ATRC
|
48.1 | $ 42.08 | 1.62 % | $ 1.98 B | USA |
 |
Atrion Corporation
ATRI
|
25.8 | - | - | $ 810 M | USA |
 |
electroCore
ECOR
|
1.45 | $ 4.81 | -0.21 % | $ 26.5 K | USA |
 |
Harvard Bioscience
HBIO
|
70.9 | $ 0.76 | 1.78 % | $ 32.2 M | USA |
 |
AngioDynamics
ANGO
|
-102 | $ 13.12 | -2.42 % | $ 536 M | USA |
 |
The Cooper Companies
COO
|
34.6 | $ 81.82 | -0.36 % | $ 16.3 B | USA |
 |
ICU Medical
ICUI
|
23.5 | $ 147.72 | 0.34 % | $ 3.6 B | USA |
 |
Glaukos Corporation
GKOS
|
-908 | $ 109.57 | 0.31 % | $ 5.31 B | USA |
 |
Haemonetics Corporation
HAE
|
12.9 | $ 83.2 | -1.49 % | $ 4.19 B | USA |
 |
InfuSystem Holdings
INFU
|
15.8 | $ 9.24 | 0.33 % | $ 191 M | USA |
 |
Isoray
ISR
|
18.4 | - | 0.03 % | $ 108 M | USA |
 |
Repro Med Systems
KRMD
|
-17.1 | $ 5.75 | -1.88 % | $ 262 M | USA |
 |
LeMaitre Vascular
LMAT
|
22.8 | $ 83.51 | 0.18 % | $ 1.87 B | USA |
 |
Intuitive Surgical
ISRG
|
49.3 | $ 541.3 | -1.11 % | $ 192 B | USA |
 |
Masimo Corporation
MASI
|
40.8 | $ 138.1 | -2.25 % | $ 7.36 B | USA |
 |
Merit Medical Systems
MMSI
|
25 | $ 86.52 | -0.01 % | $ 5.04 B | USA |
 |
Microbot Medical
MBOT
|
-2.17 | $ 2.43 | 2.21 % | $ 24.8 M |  Israel |
 |
Nephros
NEPH
|
-8.71 | $ 5.08 | 2.24 % | $ 52.8 M | USA |
 |
NeuroMetrix
NURO
|
-2.11 | - | 5.05 % | $ 9.02 M | USA |
 |
ResMed
RMD
|
35.2 | $ 250.7 | -0.67 % | $ 36.6 B | USA |
 |
Envista Holdings Corporation
NVST
|
15.7 | $ 21.79 | -1.58 % | $ 3.75 B | USA |
 |
OraSure Technologies
OSUR
|
361 | $ 2.52 | -2.14 % | $ 188 M | USA |
 |
Pro-Dex
PDEX
|
20.7 | $ 43.83 | 0.6 % | $ 144 M | USA |
 |
Pulse Biosciences
PLSE
|
-5.21 | $ 14.26 | 3.71 % | $ 685 M | USA |
 |
Predictive Oncology
POAI
|
1.29 | $ 5.95 | 0.51 % | $ 32.4 M | USA |
 |
Repligen Corporation
RGEN
|
70.6 | $ 156.65 | -3.1 % | $ 8.73 M | USA |
 |
Retractable Technologies
RVP
|
3.35 | $ 0.83 | -0.31 % | $ 24.8 M | USA |
 |
STAAR Surgical Company
STAA
|
89 | $ 24.16 | -2.11 % | $ 1.19 B | USA |
 |
STERIS plc
STE
|
29.7 | $ 251.01 | -0.59 % | $ 24.7 B | USA |
 |
Stereotaxis
STXS
|
-28.2 | $ 2.38 | -1.45 % | $ 192 M | USA |
 |
Teleflex Incorporated
TFX
|
21.2 | $ 125.81 | -1.13 % | $ 5.89 B | USA |
 |
Utah Medical Products
UTMD
|
14.1 | $ 57.99 | 0.5 % | $ 210 M | USA |
 |
West Pharmaceutical Services
WST
|
33.1 | $ 266.92 | -2.06 % | $ 19.5 B | USA |